drugset / Trial / NCT00380068
Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this study was to evaluate the safety and efficacy of ambrisentan in a broad population of participants with pulmonary hypertension (PH). Secondary objectives of this study were to evaluate the effects of ambrisentan on other clinical measures of pulmonary arterial hypertension (PAH), long-term treatment success, and survival.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-07
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ambrisentan | Small molecule | — | Oral |